Save this event to your calendar.
UCLA CTSI KL2 Program
Dental, Oral and Craniofacial Clinical and Translational Research Career Development Award
Request for Applications (RFA)
This is an internal competition to select up to two candidates for final submission of administrative supplements to NIDCR.
Important Dates (subject to change)
CTSI letter of intent deadline | June 15, 2022 by 5:00 PM |
CTSI full application deadline | July 15, 2022 by 5:00 PM |
Decision notifications to applicants | Mid-August 2022 |
Selected candidates: proposal enhancement and other supplement application components |
Mid-August to August 24, 2022
|
CTSI administrative grant review deadline | August 25, 2022 |
NIH deadline | September 15, 2022 |
Expected grant start date
|
June 1, 2023 |
National Institute of Dental and Craniofacial Research (NIDCR) Supplements to the National Center for Advancing Translational Sciences (NCATS) KL2 Program
The UCLA CTSI KL2 Program seeks up to two highly qualified junior faculty from one of the four partnered institutions (UCLA, Cedars-Sinai, Charles R. Drew University, and The Lundquist Institute at Harbor-UCLA) to conduct rigorous clinical and translational research aimed at improving dental, oral, and craniofacial health.
The goal of this NIDCR KL2 administrative supplement program is to engage the participation of scholars pursuing clinical and translational research training to improve dental, oral, and craniofacial health. For this KL2 supplement program, scholars must be pursuing clinical and translational research in dental, oral, or craniofacial science that aligns with NIDCR extramural grant programs.
NIDCR KL2 Supplement Award
This award will be contingent on the successful competition of the NIDCR administrative supplement to the NCATS KL2 Program. If funded, NIDCR KL2 supplement awardees will receive up to 3 years of funding or until receipt of an individual NIH K award (or equivalent grant from the Veterans Administration or foundation), whichever comes first. The award is renewable for up to a total of 3 years. Continued KL2 support in years 2 and 3 will be contingent the awardee’s performance during the prior year(s). The following table lists the maximum allowable amounts per year:
NIDCR KL2 Scholar Salary (75% effort) | $75,000
|
NIDCR KL2 Scholar Fringe Benefits (UCLA CBR at 32%) | $24,000 |
Research Expenses (UCLA applicants include Technology Infrastructure Fee)
Career Development/Tuition Travel to research meetings, workshops Statistical Services |
$31,000 |
Mentor Support for laboratory or other research-related expenses. Salary support for mentors is not an allowable budget item |
$10,000 |
DIRECT COSTS/YEAR | $140,000 |
F&A (Indirect Costs) at 8% | $11,200 |
TOTAL COSTS/YEAR | $151,200 |
Eligibility Criteria
UCLA CTSI Letter of Intent & Full Application Submission Information
The Letter of Intent must include:
To be considered, the Full Application packet must include the items below. General instructions can also be found in the NIH Application Guide. Please write your application in third person.
1. Project Summary/Abstract (30 lines of text maximum)
2. NIDCR KL2 Scholar NIH-formatted Biosketch (see NOT-OD-21-073 / NOT-OD-21-110 for new format changes and details). The personal statement of the candidate’s biographical sketch should include a description of his/her research objectives and career goals, and why their experience and qualifications make them particularly well-suited to receive an NIDCR KL2 supplement award. Relevant factors include previous training and research accomplishments in dental, oral, and craniofacial research and any source(s) of current research funding. The description should include a description of how the supplement will further the candidate’s career goals.
3. NIDCR KL2 Scholar NIH-formatted Other Support Pages (old format) with current, past and pending grants. Please see the NIH policy concerning concurrent support from a K award and a research grant.
4. Program Plan (10 pages maximum) to include the following:
o Program Faculty (3 pages maximum): Provide information about the program faculty who will be involved in the supplement activities, including their complementary expertise and experiences, active research and other scholarly activities in which the faculty are engaged, as well as experience mentoring individuals at the proposed career stage. If any co-mentor is not located at the sponsoring institution, describe the frequency and type of communication that will be used to engage the scholar.
o Proposed Research Career Development Plan (5 pages maximum): Format for this career development plan should include an educational/training plan and research plan similar to a traditional NIH career development award proposal.
o Candidate’s Personal Statement (2 pages maximum): Describe prior research experiences and accomplishments, short- and long-term research objectives and career goals, including plans for submission of an independent K, R, or other type of NIDCR independent award to support dental, oral, and craniofacial research and how the supplement research experience will contribute to these goals.
o Institutional Environment and Commitment to Training (1 page maximum): Include a signed letter, on institutional letterhead, that describes the applicant institution’s commitment to the planned KL2 supplement program. The letter should provide assurance that the scholar will be able to devote a minimum of 9 person-months (75% of full-time professional effort) to their KL2 research career development program. The remaining effort should be devoted to activities related to the development of the scholar’s career as an independent investigator or clinician-scientist, e.g., clinic responsibilities, teaching and administration, and/or additional research activities.
6. Letters of Support from the Primary Mentor and Co-mentors(s) (6 pages maximum): Appropriate letters of support should be provided from all individuals confirming their roles in the proposed supplement program. Primary and co-mentor(s) should include a statement of commitment to provide appropriate guidance and supervision of the candidate's research experience that supports an independent research career trajectory.
7. Letters of Support from Collaborators, Contributors, and Consultants (6 pages maximum): Attach appropriate letters from all individuals confirming their roles in the proposed KL2 supplement program.
8. Mentoring Team NIH-formatted Biosketches of each of the individuals who will comprise the scholar’s mentoring team (see NOT-OD-21-073 / NOT-OD-21-110 for new format changes and details). The personal statements of the individuals who will serve as mentors or are on the scholar's mentoring team should include a description of their specific role in mentoring the scholar.
9. NIH-formatted Detailed Budget and Budget Justification for each year of the three years of support. Please use a separate Form Page 4 for the detailed budget for each year.
10. Protection of Human Subjects: Complete this section if the scholar will design and conduct their own independent human subjects research and indicate that the proposed research experience was approved by the human subjects Institutional Review Board (IRB) at the grantee institution. If available, also include a copy of the IRB approval notice.
11. Vertebrate Animals: Complete this section if the scholar will design and conduct their own independent vertebrate animal research and indicate that the proposed research experience was approved by the Institutional Animal Care and Use Committee (IACUC) at the grantee institution. If available, also include a copy of the IACUC approval notice.
12. Facilities and Other Resources: Describe how the scientific environment in which the career development activities will be done contributes to the probability of the scholar’s success (e.g., institutional support, physical resources, and intellectual rapport).
13. Bibliography & References Cited
14. Appendix (optional).
15. Applicants will be asked to complete NIH Clinical Trials Decision Questions. Depending on the type of study, selected candidates will need to complete the required sections of PHS Human Subjects and Clinical Trials Information form for final submission to NIDCR.
NIH Fonts and Margins Tips
Proposal enhancement: Selected KL2 applications will be discussed with the UCLA CTSI KL2 program director, Dr. Mitchell Wong, in early August based on the review critiques aiming to enhance the competitiveness of the supplement application to NIDCR.
Questions about the RFA can be directed to the KL2 Program at CTSIWD@mednet.ucla.edu.